Research.Patient.info
Non-alcoholic Fatty Liver Disease research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE2
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
This study is looking into a new medicine called efinopegdutide for a liver condition called MASH. We want to see if it can help reduce liver fat, swelling, and scarring in people with MASH and mild scarring. It also checks how safe the medicine is.
United States · Australia · Canada - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study to compare two different aramchol formulations in healthy volunteers.
This study is testing two versions of a drug called aramchol in healthy people. It aims to see how safe they are and how the body handles them. This information helps scientists learn more about how to treat liver conditions like fatty liver disease.
Bulgaria